摘要
将72例次医院内感染患者按治疗方法的不同分为两组：①氨曲南治疗组36例40例次（简称治疗组）；②头孢氨噻肟治疗组32例（简称对照组），回顾性地比较两组方案治疗医院内感染患者的疗效，结果示：①治疗组的痊愈率、显效率、好转率和无效率与对照组比较差异有显著性（分别为75．0％vs50．0％、22．5％vs28．1％、2．5％vs15．6％、0．0％vs6．25％，P＜0．05）;②治疗组细菌清除率与对照组比较差异有显著性（90．32％vs69．23％，P＜0．05）。表明对采用氨曲南治疗革兰氏阴性杆菌感染的患者具有疗效好、细菌清除率高、副作用少等优点。
72 cases of hospital acquired infection were divided into two groups at random: Azactam group (refer to as treatment group, n = 40) and Cefuroxime group (refer to as contral group, n= 32). The purpose is to observe the clinical results of Azactam in hospital acquired infections patients. The results show: ①There are differences between treatment and control groups by statistics, in recovery rates, effective rates. Compromise rates and No-effection rates (75% vs 50%,22. 5 (75. 0% vs 50. 0%、22. 5% vs 28. 1%、 2． 5% vs 15. 6%. 0. 0% vs 6. 25%,Prt0. 05). ② There is defference in both groups in bacterial clear ance rate (90.32% vs 69. 23% , P<0. 05 ). This study indicates that Azactam has many good drug fumctions for treatment of gram-negative bacillus, such as high bacterial clearance rates and less side-effect.
出处
《医学新知》
CAS
1997年第3期103-105,共3页
New Medicine
